Will Genome Modifications Define Next-Gen AAV Vectors?
UF researcher Arun Srivastava, Ph.D., a gene therapy pioneer, shares his expert perspective on genome-modified AAV vectors, offering insights into how next-generation viral therapies may be shaped by precision genetic engineering.
Water Researchers Develop Prediction System for Harmful Algae
UF researchers have developed a next-day prediction model for harmful algal blooms, providing water managers with timely tools to mitigate environmental and public health risks.
Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
UF Audio Deepfakes Study Could Ultimately Help Hearing-Impaired Detect Fraud
UF researchers found that cochlear implant users are more vulnerable to audio deepfakes, highlighting the need for better detection systems to protect the hearing-impaired from potential fraud.
Dalir Joins National Effort To Enable 3D Optical Packaging for Next-Gen AI Chips
UF researcher Hamed Dalir, Ph.D., is collaborating on a $5.2 million federally funded project to develop a transformative 3D optical packaging platform that enables scalable, high-bandwidth, energy-efficient chip-to-chip optical communication.
UF Scientists Join European Effort To Develop Antiviral Drugs for Future Pandemics
UF researchers have joined a European research network that aims to develop broad-spectrum antiviral drugs to combat the next global pandemic.
The Conversation: Researchers Uncovered Hundreds of Genes Linked to OCD, Providing Clues About How It Changes the Brain
UF researchers Carol Mathews contribute to a groundbreaking international study uncovering genetic factors linked to Obsessive-Compulsive Disorder, paving the way for enhanced understanding and treatment of the condition.
Seeding Exploration
UF researchers Rob Ferl and Anna-Lisa Paul are advancing space agriculture by successfully growing plants in lunar soil, a breakthrough that supports the future of human space exploration.
Genascence Phase 1b DONATELLO Trial Evaluating Potential First-in-Class Gene Therapy for Knee Osteoarthritis (OA) Meets Primary Endpoint Showing GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation announced positive 12-month safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001, a potential first-in-class gene therapy blocking interleukin 1 (IL-1) for the treatment of knee osteoarthritis (OA).
Find Out Why Entrepreneurs in Gainesville Thrive Here
Gainesville’s thriving entrepreneurial ecosystem, supported by UF Innovate, is exemplified by the success of UF startup MYOLYN, known for its rehabilitation technology, and UF Innovate | Accelerate client Slice Engineering, a leader in 3D printing components.
